AAAAAA

   
Results: 1-9 |
Results: 9
Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors
Authors: Hartmann, JT Fossa, SD Nichols, CR Droz, JP Horwich, A Gerl, A Beyer, J Pont, J Fizazi, K Hecker, H Kanz, L Einhorn, L Bokemeyer, C
Citation: Jt. Hartmann et al., Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors, J NAT CANC, 93(22), 2001, pp. 1733-1738
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: Results of an international multicenter analysis
Authors: Hartmann, JT Einhorn, L Nichols, CR Droz, JP Horwich, A Gerl, A Fossa, SD Beyer, J Pont, J Schmoll, HJ Kanz, L Bokemeyer, C
Citation: Jt. Hartmann et al., Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: Results of an international multicenter analysis, J CL ONCOL, 19(6), 2001, pp. 1641-1648
Diagnostic and therapeutic quandaries in a patient with a germ cell tumor
Authors: Hanna, N Kesler, K Einhorn, L
Citation: N. Hanna et al., Diagnostic and therapeutic quandaries in a patient with a germ cell tumor, J CL ONCOL, 19(20), 2001, pp. 4088-4088
Extragonadal seminoma - An international multicenter analysis of prognostic factors and long term treatment outcome
Authors: Bokemeyer, C Droz, JP Horwich, A Gerl, A Fossa, SD Beyer, J Pont, J Schmoll, HJ Kanz, L Einhorn, L Nichols, CR Hartmann, JT
Citation: C. Bokemeyer et al., Extragonadal seminoma - An international multicenter analysis of prognostic factors and long term treatment outcome, CANCER, 91(7), 2001, pp. 1394-1401
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors
Authors: Hartmann, JT Nichols, CR Droz, JP Horwich, A Gerl, A Fossa, SD Beyer, J Pont, J Fizazi, K Einhorn, L Kanz, L Bokemeyer, C
Citation: Jt. Hartmann et al., Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors, J NAT CANC, 92(1), 2000, pp. 54-61
Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells
Authors: Abonour, R Williams, DA Einhorn, L Hall, KM Chen, J Coffman, J Traycoff, CM Bank, A Kato, I Ward, M Williams, SD Hromas, R Robertson, MJ Smith, FO Woo, D Mills, B Srour, EF Cornetta, K
Citation: R. Abonour et al., Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells, NAT MED, 6(6), 2000, pp. 652-658
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors
Authors: Hartmann, JT Nichols, CR Droz, JP Horwich, A Gerl, A Fossa, SD Beyer, J Pont, J Einhorn, L Kanz, L Bokemeyer, C
Citation: Jt. Hartmann et al., The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors, CANCER, 88(11), 2000, pp. 2629-2635
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis
Authors: Bokemeyer, C Kollmannsberger, C Meisner, C Harstrick, A Beyer, J Metzner, B Hartmann, JT Schmoll, HL Einhorn, L Kanz, L Nichols, C
Citation: C. Bokemeyer et al., First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis, J CL ONCOL, 17(11), 1999, pp. 3450-3456
Vinblastine versus vinblastine plus oral estramustine phosphate for patients with hormone-refractory prostate cancer: A Hoosier Oncology Group and Fox Chase network phase III trial
Authors: Hudes, G Einhorn, L Ross, E Balsham, A Loehrer, P Ramsey, H Sprandio, J Entmacher, M Dugan, W Ansari, R Monaco, F Hanna, M Roth, B
Citation: G. Hudes et al., Vinblastine versus vinblastine plus oral estramustine phosphate for patients with hormone-refractory prostate cancer: A Hoosier Oncology Group and Fox Chase network phase III trial, J CL ONCOL, 17(10), 1999, pp. 3160-3166
Risultati: 1-9 |